Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Heron Therapeutics (HRTX) Other Non Operating Income: 2010-2024

Historic Other Non Operating Income for Heron Therapeutics (HRTX) over the last 14 years, with Dec 2024 value amounting to $430,000.

  • Heron Therapeutics' Other Non Operating Income fell 2807.44% to -$11.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.6 million, marking a year-over-year decrease of 555.77%. This contributed to the annual value of $430,000 for FY2024, which is 23.21% down from last year.
  • Heron Therapeutics' Other Non Operating Income amounted to $430,000 in FY2024, which was down 23.21% from $560,000 recorded in FY2023.
  • In the past 5 years, Heron Therapeutics' Other Non Operating Income ranged from a high of $560,000 in FY2023 and a low of -$6.5 million during FY2022.
  • Moreover, its 3-year median value for Other Non Operating Income was $430,000 (2024), whereas its average is -$1.8 million.
  • Per our database at Business Quant, Heron Therapeutics' Other Non Operating Income crashed by 643.74% in 2022 and then skyrocketed by 108.58% in 2023.
  • Yearly analysis of 5 years shows Heron Therapeutics' Other Non Operating Income stood at -$847,000 in 2020, then declined by 3.66% to -$878,000 in 2021, then tumbled by 643.74% to -$6.5 million in 2022, then surged by 108.58% to $560,000 in 2023, then fell by 23.21% to $430,000 in 2024.